Role of alpha adrenoceptors and nitric oxide on cardiovascular responses in acute and chronic hypertension

Journal of Physiology and Biochemistry

Volumn 67, Issue 3, 2011, Pages 427-435

  Hong, Enrique ^a   Larios, Francisco ^a   Gómez Viquez, Norma L ^a   Huang, Fengyang ^b   Bravo, Guadalupe ^a  

^a DEPARTAMENTO DE FÍSICA   (Mexico)

^b HOSPITAL INFANTIL DE MÉXICO FEDERICO GÓMEZ   (Mexico)

Author keywords

Coarcted hypertensive rats; Nitric oxide; Pithed aortic rats; Adrenoceptors

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA ADRENERGIC RECEPTOR; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NORADRENALIN; PRAZOSIN; YOHIMBINE;

ANIMAL; AREA UNDER THE CURVE; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR SYSTEM; DRUG ANTAGONISM; DRUG EFFECT; ELECTROSTIMULATION; HEART RATE; HYPERTENSION; MALE; METABOLISM; PATHOPHYSIOLOGY; RAT; VAGOTOMY; WISTAR RAT;

ADRENERGIC ALPHA-1 RECEPTOR ANTAGONISTS; ADRENERGIC ALPHA-2 RECEPTOR ANTAGONISTS; ADRENERGIC ALPHA-AGONISTS; ANIMALS; AREA UNDER CURVE; BLOOD PRESSURE; CARDIOVASCULAR SYSTEM; ELECTRIC STIMULATION; HEART RATE; HYPERTENSION; MALE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NOREPINEPHRINE; PRAZOSIN; RATS; RATS, WISTAR; RECEPTORS, ADRENERGIC, ALPHA; VAGOTOMY; YOHIMBINE;

EID: 84856380740     PISSN: 11387548     EISSN: 18778755     Source Type: Journal    
DOI: 10.1007/s13105-011-0093-3     Document Type: Article

References (19)

1. Barton CH, Ni Z, Vaziri ND (2001) Enhanced nitric oxide inactivation in aortic coarctation-induced hypertension. Kidney Int 60:1083-1087 (Pubitemid 34205808)
2. Beznák M (1956) Hemodynamic changes following aortic constriction in normal and in hypophysectomized rats. Can J Biochem Physol 34:791-798
3. Bucher B, Ouedraogo S, TschoplM, Paya D, Stocket JC (1992) Role of the L-arginine-NO pathway and of cyclic GMP in electrical field-induced noradrenaline release and vasoconstriction in the rat tail artery. Br J Pharmacol 107:976-982
4. Cordellini S, Novo R, Júnior UL (2006) Exposure to stress: differential vascular adaptive response in spontaneously hypertensive and Wistar rats: role of nitric oxide, and prehypertensive and hypertensive states. Life Sci 79:646-653 (Pubitemid 43927975)
5. Damase-Michel C, Tran MA, Llau ME, Chollet F, Senard JM, Guiraud-Chaumeil B et al (1993) The effect of yohimbine on sympathetic responsiveness in essential hypertension. Eur J Clin Pharmacol 44:199-201 (Pubitemid 23047759)
6. de Champlain J (1990) Pre- and postsynaptic adrenergic dysfunctions in hypertension. J Hypertens Suppl 8:S77-S85
7. Egan B (1992) Vascular reactivity, sympathetic tone, and stress. In: Johnson E, Gentry W, Julius S (eds) Personality, elevated blood pressure and essential hypertension. Hemisphere, Washington, DC
8. Egi Y, Matsumura Y, Murata S, Umekawa T, Hisaki K, Takaoka M et al (1994) The effects of N-G-nitro-Larginine, a nitric oxide synthase inhibitor, on norepinephrine overflow and antidiuresis induced by stimulation of renal nerves in anesthetized dog. J Pharmacol Exp Ther 269:529-535
9. Gillespie JS, Muir TC (1967) A method of stimulating the complete sympathetic outflow from the spinal cord to blood vessels in the pithed rat. Brit J Pharmac Chemother 30:78-87
10. Green LC, Tannenbaum SR, Goldman P (1981) Nitrate synthesis in the germfree and conventional rat. Science 212:56-58 (Pubitemid 11114678)
11. Greenberg SS, Diecke FP, Peevy K, Tanaka TP (1989) The endothelium modulates adrenergic neurotransmission to canine pulmonary arteries and veins. Eur J Pharmacol 162:67-80 (Pubitemid 19074878)
12. Hatanaka Y, Hobara N, Honghua J, Akiyama S, Nawa H, Kobayashi Y, Takayama F, Gomita Y, Kawasaki H (2006) Neuronal nitric-oxide synthase inhibition facilitates adrenergic neurotransmission in rat mesenteric resistance arteries. J Pharmacol Exp Ther 316:490-497 (Pubitemid 43130974)
13. Jonsson JR, Head RJ, Frewin DB (1992) Effect of alpha 1-adrenoceptor blockade on the development of hypertension in the spontaneously hypertensive rat. Eur J Pharmacol 211:263-268
14. Julius S, Majahalme S (2000) The changing face of sympathetic overactivity in hypertension. Ann Med 32:365-370 (Pubitemid 30495208)
15. Julius S, Nesbitt S (1996) Sympathetic overactivity in hypertension. A moving target. Am J Hypertens 9:113S-120S
16. Miyajima E, Yamada Y, Yoshida Y, Matsukawa T, Shinoiri H, Tochikubo O et al (1991) Muscle sympathetic nerve activity in renovascular hypertension and primary aldosteronism. Hypertension 17:1057-1062
17. Ruffolo RR, Nichols AJ, Stadel JM, Hieble JP (1993) Pharmacologic and therapeutic applications of alpha-2 adrenoceptor subtypes. Annu Rev Pharmacol Toxicol 32:243-279 (Pubitemid 23116008)
18. Sessa WC, Pritchard K, Seyedi N, Wang J, Hintze TH (1994) Chronic exercise in dogs increases coronary vascular nitric oxide production and endothelial cell nitric oxide synthase gene expression. Circ Res 74:349-353 (Pubitemid 24029168)
19. Shipley RE, Tilden JH (1947) A pithed rat preparation suitable for assaying pressor substances. Proc Soc Exp Biol Med 64:453-455